| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000013485 |
| Receipt No. | R000015748 |
| Scientific Title | Prospective observational study of the relationship between periodontal disease and lifestyle-related disease monitored by atherosclerosis-related biomarkers |
| Date of disclosure of the study information | 2014/03/23 |
| Last modified on | 2019/10/02 (Ver. 6) |
| Basic information | ||
| Public title | Prospective observational study of the relationship between periodontal disease and lifestyle-related disease monitored by atherosclerosis-related biomarkers | |
| Acronym | Prospective observational study of the relationship between periodontal disease and lifestyle-related disease monitored by atherosclerosis-related biomarkers | |
| Scientific Title | Prospective observational study of the relationship between periodontal disease and lifestyle-related disease monitored by atherosclerosis-related biomarkers | |
| Scientific Title:Acronym | Prospective observational study of the relationship between periodontal disease and lifestyle-related disease monitored by atherosclerosis-related biomarkers | |
| Region |
|
|
| Condition | ||||||
| Condition | Periodontal disease | |||||
| Classification by specialty |
|
|||||
| Classification by malignancy | Others | |||||
| Genomic information | NO | |||||
| Objectives | |
| Narrative objectives1 | To evaluate the relationship between periodontal disease and lifestyle-related disease such as diabetes mellitus, dyslipidemia, and hypertension or atherosclerosis by monitoring related biomarkers |
| Basic objectives2 | Others |
| Basic objectives -Others | Relationship between periodontal disease and lifestyle-related disease or atherosclerosis-related biomarkers |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Cross-sectional evaluation of the relationship between clinical parameters of periodontitis and incidence of lifestyle-related disease (diabetes mellitus, dyslipidemia, and hypertension) or atherosclerosis |
| Key secondary outcomes | 1) Analysis of biomarkers and laboratory parameters related to diabetes mellitus, dyslipidemia, hypertension and atherosclerosis
Serum markers hsCRP IL-6 TNF-alpha oxidized LDL Remnant small dense LDL HDL2 (HDL3) Adiponectin Myeloperoxidase (MPO) Podocalyxin Proproteinconvertase subtilisin/kexin type 9 Antibody against periodontopathic bacteria Urinary markers Megalin Podocalyxin Alpha1MG Beta2MG N-acetyl-beta-D-glucosaminidase (NAG) Albumin Neutrophil gelatinase-associated lipocalin (NGAL) L-type fatty acid binding protein (L-FABP) etc. 2) Intestinal flora Meta 16S rRNA gene analysis 3) PWV/ABI |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Those who have given written informed consent on the use of their data for the study | |||
| Key exclusion criteria | Those who are considered not eligible for the study by attending doctors due to any medical reasons | |||
| Target sample size | 190 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Niigata University Graduate School of Medical and Dental Sciences | ||||||
| Division name | Department of Applied Molecular Medicine | ||||||
| Zip code | 951-8510 | ||||||
| Address | 1-757 Asahimachi-dori, Chuo-ku, Niigata-shi | ||||||
| TEL | 025-227-0915 | ||||||
| akisaito@med.niigata-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Niigata University Graduate School of Medical and Dental Sciences | ||||||
| Division name | Department of Applied Molecular Medicine | ||||||
| Zip code | 951-8510 | ||||||
| Address | 1-757 Asahimachi-dori, Chuo-ku, Niigata-shi | ||||||
| TEL | 025-227-0915 | ||||||
| Homepage URL | |||||||
| akisaito@med.niigata-u.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Applied Molecular Medicine, Niigata University Graduate School of Medical and Dental Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | DENKA SEIKEN Co.,Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | Ministry of Education, Culture, Sports, Science and Technology |
| IRB Contact (For public release) | |
| Organization | Department of Applied Molecular Medicine, Niigata University Graduate School of Medical and Dental Sciences |
| Address | 1-757 Asahimachi-dori, Chuo-ku, Niigata-shi |
| Tel | 025-227-0915 |
| akisaito@med.niigata-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | コープケミカル株式会社(新潟県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | https://onlinelibrary.wiley.com/doi/full/10.1111/jre.12533 |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | https://onlinelibrary.wiley.com/doi/full/10.1111/jre.12533 | ||||||
| Number of participants that the trial has enrolled | 131 | ||||||
| Results | In conclusion, serum PCSK9 and TBIL were identified as potential biomarkers correlated with periodontal parameters. Serum PCSK9 could be a candidate biomarker in the diagnosis of chronic periodontitis with potential ability to evaluate the risk of periodontitis to alter the concentration of serum lipids, and thus promote ASVD. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | The study cohort included a total of 131 industrial employees (119 male subjects, 12 female subjects) who underwent annual health examinations in Niigata City, Japan. |
||||||
| Participant flow | A total of 108 male subjects were finally included for analysis after subjects with fewer than 15 teeth and women (because of the small number of female subjects) were excluded to avoid potential bias. |
||||||
| Adverse events | none |
||||||
| Outcome measures | (Serum markers) hsCRP IL-6 TNF-a oxidized LDL Remnant small dense LDL HDL2, HDL3 Adiponectin Myeloperoxidase (MPO) Podocalyxin Proproteinconvertase subtilisin/kexin type 9 Antibody against periodontopathic bacteria (Urinary markers) Megalin Podocalyxin a1MG b2MG N-acetyl-B-D-glucosaminidase (NAG) Albumin Neutrophil gelatinase-associated lipocalin (NGAL) L-type fatty acid binding protein (L-FABP) |
||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Relationship between clinical parameters of periodontitis and incidence of lifestyle-related disease (diabetes mellitus, dyslipidemia, and hypertension) or atherosclerosis |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015748 |